Fritextsökning
Artiklar per år
Innehållstyper
-
Robotforskaren Eve gör egna QSAR-experiment
Roboten Eve har utvecklas i ett EU-projekt och kan inte bara utföra experiment automatiskt utan även - i viss mån - planera dem.
-
Från skogsindustriell forskning till mångvetenskapligt ledarskap: KTH-professor ska förnya finsk forskning
Hon kom till Sverige och KTH som gästprofessor för 13 år sedan. I april återvänder Tuula Teeri till Finland med akademiska meriter som professor och prorektor i bagaget. Den nya titeln är rektor för det tvärvetenskapliga Aalto-universitetet i Helsingfors.
-
Ny plattform för singelcellanalys från Picovitro
Picovitro lanserar en förnyande plattform som möjliggör analys av enskilda celler.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten Drejer, CEO of Symphogen. Ph.D.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
A smart company takes care of its best
Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.
-
Fusion between pharma giants?
It is rumoured that a fusion between Pfizer and Wyeth is in the process of happening.
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
Biovitrum sells UK part
Biovitrum will soon spin-out a British subsidary
-
Medicult needs a word of advice
Medicult Board retains advisers, regarding the previous offer from Vitrolife.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
BREAKING